134 related articles for article (PubMed ID: 27246634)
1. Medullary thyroid carcinoma as manifestation of the loss of heterozygosity in a patient with MEN1.
Aranda Velazquez GB; Porta MM; Martínez D; Oriola J; Halperin Rabinovich I
Endocrinol Nutr; 2016; 63(7):371-3. PubMed ID: 27246634
[No Abstract] [Full Text] [Related]
2. Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1.
Ozturk M; Chiu CY; Akdeniz N; Jenq SF; Chang SC; Hsa CY; Jap TS
J Endocrinol Invest; 2006 Jun; 29(6):523-7. PubMed ID: 16840830
[TBL] [Abstract][Full Text] [Related]
3. Incidental occurrence of metastatic medullary thyroid carcinoma in a patient with multiple endocrine neoplasia type 1 carrying germline MEN1 and somatic RET mutations.
Cetani F; Pardi E; Berardi V; Romei C; Marcocci C; Elisei R
J Surg Oncol; 2017 Dec; 116(8):1197-1199. PubMed ID: 28968916
[No Abstract] [Full Text] [Related]
4. Multiple endocrine neoplasia type 1: atypical presentation, clinical course, and genetic analysis of multiple tumors.
Vortmeyer AO; Lubensky IA; Skarulis M; Li G; Moon YW; Park WS; Weil R; Barlow C; Spiegel AM; Marx SJ; Zhuang Z
Mod Pathol; 1999 Sep; 12(9):919-24. PubMed ID: 10496602
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in sporadic parathyroid tumours: involvement of chromosome 1 and the MEN1 gene locus in 11q13.
Dwight T; Twigg S; Delbridge L; Wong FK; Farnebo F; Richardson AL; Nelson A; Zedenius J; Philips J; Larsson C; Teh BT; Robinson B
Clin Endocrinol (Oxf); 2000 Jul; 53(1):85-92. PubMed ID: 10931084
[TBL] [Abstract][Full Text] [Related]
6. Syndromic MEN1 parathyroid adenomas consist of both subclonal nodules and clonally independent tumors.
Bräutigam K; Nesti C; Riss P; Scheuba C; Niederle B; Grob T; Di Domenico A; Neuenschwander M; Mazal P; Köhn N; Trepp R; Perren A; Kaderli RM
Virchows Arch; 2024 May; 484(5):789-798. PubMed ID: 38244045
[TBL] [Abstract][Full Text] [Related]
7. An unusual kindred of the multiple endocrine neoplasia type 1 (MEN1) in Japanese.
Abe T; Yoshimoto K; Taniyama M; Hanakawa K; Izumiyama H; Itakura M; Matsumoto K
J Clin Endocrinol Metab; 2000 Mar; 85(3):1327-30. PubMed ID: 10720085
[No Abstract] [Full Text] [Related]
8. Primary hyperparathyroidism associatiated with aldosterone-producing adrenocortical adenoma and breast cancer: relation to MEN1 gene.
Honda M; Tsukada T; Horiuchi T; Tanaka R; Yamaguchi K; Obara T; Miyakawa H; Yamaji T; Ishibashi M
Intern Med; 2004 Apr; 43(4):310-4. PubMed ID: 15168774
[TBL] [Abstract][Full Text] [Related]
9. Expression and functional analysis of menin in a multiple endocrine neoplasia type 1 (MEN1) patient with somatic loss of heterozygosity in chromosome 11q13 and unidentified germline mutation of the MEN1 gene.
Naito J; Kaji H; Sowa H; Kitazawa R; Kitazawa S; Tsukada T; Hendy GN; Sugimoto T; Chihara K
Endocrine; 2006 Jun; 29(3):485-90. PubMed ID: 16943588
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia type 1 variant with frequent prolactinoma and rare gastrinoma.
Hao W; Skarulis MC; Simonds WF; Weinstein LS; Agarwal SK; Mateo C; James-Newton L; Hobbs GR; Gibril F; Jensen RT; Marx SJ
J Clin Endocrinol Metab; 2004 Aug; 89(8):3776-84. PubMed ID: 15292304
[TBL] [Abstract][Full Text] [Related]
11. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
12. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
13. MEN1 and pituitary adenomas.
Delemer B
Ann Endocrinol (Paris); 2012 Apr; 73(2):59-61. PubMed ID: 22542456
[TBL] [Abstract][Full Text] [Related]
14. MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.
Cetani F; Pardi E; Vignali E; Borsari S; Picone A; Cianferotti L; Ambrogini E; Miccoli P; Pinchera A; Marcocci C
J Endocrinol Invest; 2002 Jun; 25(6):508-12. PubMed ID: 12109621
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism.
Carling T; Correa P; Hessman O; Hedberg J; Skogseid B; Lindberg D; Rastad J; Westin G; Akerström G
J Clin Endocrinol Metab; 1998 Aug; 83(8):2960-3. PubMed ID: 9709976
[TBL] [Abstract][Full Text] [Related]
16. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
17. Genetic defects associated with familial and sporadic hyperparathyroidism.
Hendy GN; Cole DE
Front Horm Res; 2013; 41():149-65. PubMed ID: 23652676
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic and molecular analyses of multiple endocrine neoplasias of the MEN1 syndrome.
Pourani J; Kaserer K; Pfragner R
Int J Oncol; 2002 May; 20(5):971-6. PubMed ID: 11956591
[TBL] [Abstract][Full Text] [Related]
19. Loss of wild-type MEN1 gene expression in multiple endocrine neoplasia type 1-associated parathyroid adenoma.
Ludwig L; Schleithoff L; Kessler H; Wagner PK; Boehm BO; Karges W
Endocr J; 1999 Aug; 46(4):539-44. PubMed ID: 10580746
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
Kameya T; Tsukada T; Yamaguchi K
Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
